BUY BSE Ltd. — Kunal Bothra
byKunal BothraHorizon: 1–3 months4 Sept 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·7 Sept · today
SEBI circular on CAS impact: Groww, Angel One, BSE shares jump up to 8% - What regulator said and investors should know
NewsLivemint·4 Sept · 2d ago
BSE share price jumps jumps 4% | extends rally for second day in a row; here's why
NewsLivemint·4 Sept · 2d ago
BSE share price jumps 4% | extends rally for second day in a row; here's why
NewsLivemint·4 Sept · 2d ago
BSE, Groww, Angel One shares rally up to 8% after Sebi’s CAS circular. What did the regulator say?
NewsEt-Markets·4 Sept · 2d ago
ESDS Software Solution IPO listing today: GMP at ₹247; Share price prediction ahead of NSE, BSE debut
NewsLivemint·4 Sept · 3d ago
NSE's unlisted shares down 17% from peak ahead of IPO; BSE falls 29%. Which is a better bet right now?
NewsEt-Markets·3 Sept · 3d ago
BSE mulling the launch of derivatives in India linked to MSCI indices. Details here
NewsLivemint·20 Aug · 2w ago
BSE launches three growth factor indices to expand factor investing suite
NewsHbl·19 Aug · 3w ago
Buy, Sell Or Hold: Canara Bank, SBI, Zen Technologies, HUL, GE Shipping, BSE, HFCL — Ask Profit
NewsNdtv-Profit·18 Aug · 3w ago
Past month's volume 1.8× the prior month's average
Technicals · volume·4 Sept · 3d ago
BSE shares slip 3% exchange flags lower volumes due to CAS
NewsEt-Markets·2 Sept · 4d ago
BSE shares slip 3% after exchange flags CAS-driven volume decline
NewsEt-Markets·2 Sept · 4d ago
Why BSE shares are falling today - CAS impact or some other trigger? Details here
NewsLivemint·2 Sept · 4d ago
Symbiotec Pharmalab IPO listing: Shares list at a 1% discount on BSE
NewsLivemint·1 Sept · 5d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.